Journal of Biological Chemistry · 2007 · 99 citations · 25 references
Life SciencesBiochemistryMicrobiologyEnzymologyMetabolismMicrobial MetabolismBacterial MetabolismCell Wall BiosynthesisFatty Acid BiosynthesisArabinogalactan BiosynthesisBacterial Cell Wall BiosynthesisBacterial Fatty Acid BiosynthesisBacterial Glycan BiosynthesisBiomolecular CondensationCell Wall BiogenesisFatty Acids
Mycolic acids are essential components of the cell walls of bacteria belonging to the suborder Corynebacterineae, including the important human pathogens Mycobacterium tuberculosis and Mycobacterium leprae. Mycolic acid biosynthesis is complex and the target of several frontline antimycobacterial drugs. The condensation of two fatty acids to form a 2-alkyl-3-keto mycolate precursor and the subsequent reduction of this precursor represent two key and highly conserved steps in this pathway. Although the enzyme catalyzing the condensation step has recently been identified, little is known about the putative reductase. Using an extensive bioinformatic comparison of the genomes of M. tuberculosis and Corynebacterium glutamicum, we identified NCgl2385, the orthologue of Rv2509 in M. tuberculosis, as a potential reductase candidate. Deletion of the gene in C. glutamicum resulted in a slow growing strain that was deficient in arabinogalactan-linked mycolates and synthesized abnormal forms of the mycolate-containing glycolipids trehalose dicorynomycolate and trehalose monocorynomycolate. Analysis of the native and acetylated trehalose glycolipids by MALDI-TOF mass spectrometry indicated that these novel glycolipids contained an unreduced β-keto ester. This was confirmed by analysis of sodium borodeuteride-reduced mycolic acids by gas chromatography mass spectrometry. Reintroduction of the NCgl2385 gene into the mutant restored the transfer of mature mycolic acids to both the trehalose glycolipids and cell wall arabinogalactan. These data indicate that NCgl2385, which we have designated CmrA, is essential for the production of mature trehalose mycolates and subsequent covalent attachment of mycolic acids onto the cell wall, thus representing a focus for future structural and pathogenicity studies. Mycolic acids are essential components of the cell walls of bacteria belonging to the suborder Corynebacterineae, including the important human pathogens Mycobacterium tuberculosis and Mycobacterium leprae. Mycolic acid biosynthesis is complex and the target of several frontline antimycobacterial drugs. The condensation of two fatty acids to form a 2-alkyl-3-keto mycolate precursor and the subsequent reduction of this precursor represent two key and highly conserved steps in this pathway. Although the enzyme catalyzing the condensation step has recently been identified, little is known about the putative reductase. Using an extensive bioinformatic comparison of the genomes of M. tuberculosis and Corynebacterium glutamicum, we identified NCgl2385, the orthologue of Rv2509 in M. tuberculosis, as a potential reductase candidate. Deletion of the gene in C. glutamicum resulted in a slow growing strain that was deficient in arabinogalactan-linked mycolates and synthesized abnormal forms of the mycolate-containing glycolipids trehalose dicorynomycolate and trehalose monocorynomycolate. Analysis of the native and acetylated trehalose glycolipids by MALDI-TOF mass spectrometry indicated that these novel glycolipids contained an unreduced β-keto ester. This was confirmed by analysis of sodium borodeuteride-reduced mycolic acids by gas chromatography mass spectrometry. Reintroduction of the NCgl2385 gene into the mutant restored the transfer of mature mycolic acids to both the trehalose glycolipids and cell wall arabinogalactan. These data indicate that NCgl2385, which we have designated CmrA, is essential for the production of mature trehalose mycolates and subsequent covalent attachment of mycolic acids onto the cell wall, thus representing a focus for future structural and pathogenicity studies. Several species of the suborder Corynebacterianeae are important human pathogens, most notably Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). 4The abbreviations used are: TB, tuberculosis; GC-MS, gas chromatography-mass spectrometry; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight; AG, arabinogalactan; TMM, trehalose monomycolate; TMCM, trehalose monocorynomycolate; TDM, trehalose dimycolate; TDCM, trehalose dicorynomycolate; HPTLC, high performance thin layer chromatography; AcPIM2, acylated phosphatidylinositol dimannoside; for, forward; rev, reverse. 4The abbreviations used are: TB, tuberculosis; GC-MS, gas chromatography-mass spectrometry; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight; AG, arabinogalactan; TMM, trehalose monomycolate; TMCM, trehalose monocorynomycolate; TDM, trehalose dimycolate; TDCM, trehalose dicorynomycolate; HPTLC, high performance thin layer chromatography; AcPIM2, acylated phosphatidylinositol dimannoside; for, forward; rev, reverse. Despite intensive efforts to control the disease, TB kills approximately 2 million people per year (1Raviglione M.C. Tuberculosis (Edinb.). 2003; 83: 4-14Crossref PubMed Scopus (243) Google Scholar). The prevalence of drug-resistant strains, including the recently identified extremely drug-resistant strains, has been labeled a global health emergency, underlying the need for new anti-mycobacterial therapies. Several current TB drugs target enzymes that synthesize the unique cell wall, an important bacterial virulence factor. The core of the cell wall consists of type 4 peptidoglycan covalently linked to arabinogalactan (AG), a polysaccharide of arabinose and galactose sugars which is, in turn, covalently linked to long chain 2-alkyl and 3-hydroxy fatty acids, the mycolic acids (2Brennan P.J. Tuberculosis (Edinb.). 2003; 83: 91-97Crossref PubMed Scopus (599) Google Scholar). These molecules vary in length from C60 to C90 in mycobacteria, but the equivalent species in corynebacteria, the corynomycolates, are significantly smaller (C22–C36) (3Barry III, C.E. Lee R.E. Mdluli K. Sampson A.E. Schroeder B.G. Slayden R.A. Yuan Y. Prog. Lipid Res. 1998; 37: 143-179Crossref PubMed Scopus (442) Google Scholar). The covalently bound mycolates form the inner leaflet of an outer lipid bilayer with a number of noncovalently bound glycolipids, including trehalose monomycolate (TMM) and trehalose dimycolate (TDM) (2Brennan P.J. Tuberculosis (Edinb.). 2003; 83: 91-97Crossref PubMed Scopus (599) Google Scholar), forming the outer leaflet. The corynebacterial equivalents, trehalose monocorynomycolate (TMCM) and trehalose dicorynomycolate (TDCM), have identical structures except that they contain the shorter corynomycolates (4Tropis M. Meniche X. Wolf A. Gebhardt H. Strelkov S. Chami M. Schomburg D. Kramer R. Morbach S. Daffe M. J. Biol. Chem. 2005; 280: 26573-26585Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar). TDM, also known as cord factor, is a well established immunostimulatory compound with toxic properties (5Oswald I.P. Dozois C.M. Petit J.F. Lemaire G. Infect. Immun. 1997; 65: 1364-1369Crossref PubMed Google Scholar, 6Chami M. Andreau K. Lemassu A. Petit J.F. Houssin C. Puech V. Bayan N. Chaby R. Daffe M. FEMS Immunol. Med. Microbiol. 2002; 32: 141-147PubMed Google Scholar). The outer lipid bilayer forms the main permeability barrier around Corynebacterineae and is the major factor in the natural resistance of these bacteria to many antibiotics, the intracellular environment of the macrophage, and environmental stresses (7Liu J. Barry III, C.E. Besra G.S. Nikaido H. J. Biol. Chem. 1996; 271: 29545-29551Abstract Full Text Full Text PDF PubMed Scopus (230) Google Scholar). The structure and biosynthesis of mycolic acids have been intensively studied because of their functional importance, uniqueness, and the finding that many drugs, including the front line TB drug isoniazid, target several enzymes involved in their biosynthesis (8Schroeder E.K. de Souza N. Santos D.S. Blanchard J.S. Basso L.A. Curr. Pharm. Biotechnol. 2002; 3: 197-225Crossref PubMed Scopus (124) Google Scholar). Although the chain length of mycolic acids varies between Corynebacterineae, many chemical features of the mycolate molecules are conserved, most notably the mycolic motif (Fig. 1A). Several of the enzymes involved in early steps of mycolic acid biosynthesis have recently been identified in Corynebacterium glutamicum, a species that can tolerate the loss of mycolic acids allowing the characterization of viable mutants that cannot be derived in mycobacteria. In a recent important study, the polyketide synthase Pks13 was identified as the condensase required for condensation of the two fatty acids to form 2-alkyl, 3-keto mycolates (11Portevin D. De Sousa-D'Auria C. Houssin C. Grimaldi C. Chami M. Daffe M. Guilhot C. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 314-319Crossref PubMed Scopus (272) Google Scholar). All of these genes are essential for life in M. tuberculosis (12Sassetti C.M. Boyd D.H. Rubin E.J. Mol. Microbiol. 2003; 48: 77-84Crossref PubMed Scopus (1961) Google Scholar), highlighting the importance of the pathway in the human pathogen. Mature mycolates generated by this pathway are thought to be passed to lipid carriers for transport across the plasma membrane, before being attached to trehalose to form TMM/TMCM and TDM/TDCM, and subsequent esterification to AG (13Takayama K. Wang C. Besra G.S. Clin. Microbiol. Rev. 2005; 18: 81-101Crossref PubMed Scopus (479) Google Scholar) (Fig. 1, B and C). The final step of mycolic acid synthesis has been proposed to involve reduction of the β-keto ester to form the mycolic motif (Fig. 1C), but little is known about this step (9Portevin D. de Sousa-D'Auria C. Montrozier H. Houssin C. Stella A. Laneelle M.A. Bardou F. Guilhot C. Daffe M. J. Biol. Chem. 2005; 280: 8862-8874Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar, 11Portevin D. De Sousa-D'Auria C. Houssin C. Grimaldi C. Chami M. Daffe M. Guilhot C. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 314-319Crossref PubMed Scopus (272) Google Scholar, 13Takayama K. Wang C. Besra G.S. Clin. Microbiol. Rev. 2005; 18: 81-101Crossref PubMed Scopus (479) Google Scholar). In this study, we describe the identification of three reductases as candidates for this enzyme, exploiting an extensive genome comparison between M. tuberculosis and C. glutamicum. Using a gene deletion approach in C. glutamicum, we show that one of these, cmrA, encodes this reductase activity as revealed by comprehensive analyses of the alterations to TDCM and TMCM in the mutant strain. Significantly, we demonstrate that reduction of the β-keto ester is important for subsequent attachment of mycolic acids to AG in Corynebacterineae. Bioinformatics Analysis—Identification of the conserved mycolate reductase and other conserved cell wall genes was undertaken by performing a FASTA BLAST comparison of every gene found in the C. glutamicum ATCC 13032 Kitasato gene list located at the TIGR comprehensive microbial resource against the M. tuberculosis H37Rv genome using the FASTA sequence analysis program. E values and best matches in the M. tuberculosis genome were assigned based on these results. Amino acid similarity percentage values were assigned according to the results found in the protein versus all alignment menu located for each gene in the aforementioned C. glutamicum ATCC 13032 Kitasato gene list. Sequences were compared utilizing ClustalW. Strains and Culture Conditions—E. coli DH5α was cultured in Luria-Bertani media at 37 °C. All C. glutamicum strains, including the wild type strain ATCC 13032, were grown in BHI media (Oxoid) at 30 °C. 15 g/liter agar was used for preparation of solid media, and 10% sucrose (w/v) was added when necessary. C. glutamicum electrocompetent were according to a C. D. Microbiol. Biotechnol. PubMed Scopus Google Scholar) except that was at the and and were added to media when necessary. of the C. glutamicum and NCgl2385 gene and were by as a using and the and according to the and into the of C. J. J. PubMed Scopus Google Scholar). sequence to the gene was by and the sequence was and into the of the A. A. J. G. A. PubMed Scopus Google Scholar). were for the of by using a using the was cultured on BHI 10% sucrose to for Deletion of the gene was by using the and and confirmed by confirmed deletion designated was for of the mutant was by the NCgl2385 gene in to of sequence and of sequence into the unique of which the Corynebacterium of and the resistance gene S. J. R. Infect. 2005; PubMed Scopus Google Scholar), The and control were into C. glutamicum and on and Analysis of were grown to wall glycolipids were as H. R.E. S. Mol. Microbiol. PubMed Scopus Google Scholar). and trehalose mycolates were in and as were from the by in and mycolates from the with S. D. J. R. R. H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). glycolipids were on in and with S. D. J. R. R. H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The and mycolate were and GC-MS, as were by the cell to in and analysis of the and MALDI-TOF Analysis of glycolipids were by HPTLC, and were in The were and glycolipids by in glycolipids were by MALDI-TOF mass spectrometry. MALDI-TOF were on a mass in the and acetylated were in and onto a with of acid in and acid were in using an at and an of was used as an glycolipids were in of for 2 at °C. were to analysis by of wall and trehalose glycolipids were to in were with and the and corynomycolates in for at °C. were by with a was with a inner and the at by a to and a to °C. was at an of and mass were from to In the trehalose glycolipids were with to were in for 2 at 4 °C. were with acid and and glycolipids were by in glycolipids were with in 37 2 and the in the The was on a and in for at to analysis by of in identification of potential reductase candidates of a to conserved cell wall biosynthesis of the between the cell wall components of and corynebacteria, we that the of cell wall biosynthesis be conserved between both new genes involved in these we every putative in the C. glutamicum ATCC 13032 Kitasato genome against the genome of M. tuberculosis H37Rv using the BLAST J. Mol. Biol. PubMed Scopus Google Scholar). genes of that are essential in slow when in M. tuberculosis, as by the of (12Sassetti C.M. Boyd D.H. Rubin E.J. Mol. Microbiol. 2003; 48: 77-84Crossref PubMed Scopus (1961) Google Scholar), were to candidates for cell wall biosynthesis genes of major structural because the of cell wall genes are to deletion to slow growing mutants when we the of C. glutamicum to a list of that these to focus on potential candidates for the conserved reductase proposed to in mycolic acid the genes found in M. tuberculosis with putative reductase R. J. C. D. K. S. Barry III, C.E. F. K. D. D. R. R. K. S. N. K. A. J. S. K. J. M.A. J. S. K. J. R. S. K. S. B.G. 1998; PubMed Scopus Google Scholar), two essential and and one which results in a slow were conserved in C. glutamicum. was an because is from the highly genome of Mycobacterium a species that a genome mycolic acids, and we were to the C. glutamicum orthologue of that encodes an essential The is highly conserved in all genomes of the Corynebacterineae, including M. K. J. N. C. D. K. D. D. R. K. S. A. N. S. K. C. J. S. K. M.A. S. K. S. M. J. R. S. K. K. S. B.G. PubMed Scopus Google Scholar). The of Rv2509 in M. and Mycobacterium and in C. glutamicum and Corynebacterium and acid to the M. tuberculosis protein (Fig. In the M. tuberculosis Rv2509 is as a putative chain type based on acid sequence similarity to a of the of an motif that a potential for the a putative motif at and the of a number of other highly conserved in the chain type reductase (Fig. Deletion of NCgl2385 in C. glutamicum in a Rv2509 is the reductase involved in mycolic motif we orthologue in C. glutamicum, to the gene was using a and mutants were by and of the gene was confirmed by of with (Fig. and derived from NCgl2385 to two in the wild type strain of and in and to one in the mutant of This was the for a mutant because one was located in the of The mutant as on solid media, and this slow was in media (Fig. of the mutant with the the NCgl2385 gene of restored a with the (Fig. The was with the slow for a M. tuberculosis Rv2509 strain (12Sassetti C.M. Boyd D.H. Rubin E.J. Mol. Microbiol. 2003; 48: 77-84Crossref PubMed Scopus (1961) Google Scholar). The of TDCM and TMCM and in analysis of noncovalently linked and glycolipids from wild type C. glutamicum and the mutant indicated that the two species in the identified as TMCM and TDCM species and the wild type glycolipids (Fig. The of these species was also in the mutant compared with wild type (Fig. In the and of other glycolipids, including and a novel species that to the recently J. M. K. N. A. Besra G.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (59) Google Scholar), were (Fig. that the species in the mutant were forms of TMCM and TDCM, these species were by and to and MALDI-TOF analysis that from wild type and from the mutant contained as the and analysis of the by GC-MS, all species were found to contain of trehalose TMCM and TDCM from wild type were by MALDI-TOF in a of were identified with the of species of TMCM and TDCM and corynomycolates (Fig. The was confirmed by analysis (Fig. and analysis of the and species from the mutant revealed a of the mass of these species were 2 4 mass smaller TMCM and TDCM, (Fig. These mass an of in the trehalose glycolipids of the of an unreduced β-keto ester motif of the mutant with a the NCgl2385 the of trehalose glycolipids and of were from wild type (Fig. The is thus because of loss of analysis of C. glutamicum wild type and the mutant trehalose MALDI-TOF mass were in the of the mass are transfer of corynomycolates to arabinogalactan is in the C. glutamicum wild type C. glutamicum C. glutamicum and C. glutamicum were and arabinogalactan and arabinogalactan-linked mycolic acids and of arabinogalactan in the cell to wild type were based on of and in the final cell of arabinogalactan-linked acids in the cell to wild type and of corynomycolates from C. glutamicum wild type and mutant cell wall The corynomycolates from the mutant have and mass from mature analysis of corynomycolates synthesized by C. glutamicum wild type and C. glutamicum C. glutamicum wild type TDCM and C. glutamicum were to and the components were by of the from TDCM The major species is mass and mass of the ester from mass and mass of the ester from The mass of and B but are by mass of into the β-keto structure of in C. glutamicum the mutant contained in other cell wall the of wild type and were to These analyses indicated that the mutant contained of and arabinogalactan (Fig. of corynomycolates were by in the mutant (Fig. the corynomycolates from the cell wall by and mass (Fig. and the that the mutant has a in acid the of cell corynomycolates was restored to wild type of the mutant with NCgl2385, is that this results in transport attachment of synthesized corynomycolates to arabinogalactan. of in in the the in mycolic acid biosynthesis in fatty acid the of a reductase the trehalose glycolipids from the wild type C. glutamicum and the mutant were and by this resulted in an in the mass of TDCM by mass to because of the of the in the trehalose and the two on the acids (Fig. In the mass of acetylated by mass compared with the the of (Fig. TDCM and contain the these results that is with corynomycolates the β-keto ester mature MALDI-TOF analysis of TMCM and indicated the of and these data that the mutant the to synthesize mature that the corynomycolates the β-keto TDCM and were with sodium and the attached fatty acids and by (Fig. reduction have on mature corynomycolates but the β-keto in corynomycolates, with of two of which be by a in the major at and in the mass of the mature ester are because of on of the R.E. K. P.J. Besra G.S. 1997; PubMed Scopus Google Scholar, C. M. C. J. PubMed Scopus Google Scholar). at results from of because of loss of the mass C. M. C. J. PubMed Scopus Google Scholar). the mass of this ester was by reduction sodium reduction of generated acids with the as wild type acids and the mass of the major ester indicated the of a (Fig. both of the major were by mass the on the This was confirmed by the that the was that the was linked to a (Fig. These data the structure of to be that in results were when the acids of were these data demonstrate that all the acids of the mutant contain a and that the mutant is deficient in acid reductase has been established that mycolic acids are by the condensation of two fatty acids by reduction of the β-keto ester motif to form the final acid M. PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar). The recent that Pks13 the condensation (11Portevin D. De Sousa-D'Auria C. Houssin C. Grimaldi C. Chami M. Daffe M. Guilhot C. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 314-319Crossref PubMed Scopus (272) Google Scholar) and that a of enzymes are involved in and of fatty acids to this step (9Portevin D. de Sousa-D'Auria C. Montrozier H. Houssin C. Stella A. Laneelle M.A. Bardou F. Guilhot C. Daffe M. J. Biol. Chem. 2005; 280: 8862-8874Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar, R. K. H. S. Besra G.S. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar) has significantly of the synthesis of these important cell wall identification of the enzyme catalyzing the final step of mycolic acid the reduction of the β-keto ester has in because of the number of putative reductases in In this we have that NCgl2385 is involved in the mycolic motif in C. glutamicum. and analysis of the novel trehalose glycolipids and mycolic acids of the mutant that all the mycolates of this mutant the β-keto ester of NCgl2385 in this mutant restored the synthesis of mature The NCgl2385 gene is highly conserved in all genomes of of Corynebacterineae and is to the activity in all including the human pathogens M. tuberculosis, M. and Mycobacterium that NCgl2385 is to Rv2509 from M. tuberculosis based on the acid similarity between the two (Fig. and between the in which the two genes are Despite NCgl2385 being located in a by genes that are from encodes a protein acid similarity and with the putative by a conserved gene from all corynebacterial Rv2509 and in M. we have designated the genes NCgl2385 and Rv2509 as cmrA, for Corynebacterineae mycolate reductase A. Deletion of in C. glutamicum resulted in of TDCM and TMCM, but a in the transfer of mycolates to cell wall arabinogalactan. This is the of a mutant most mycolates but TDCM and that the reduction of the β-keto ester motif is important for subsequent to AG but for that to the of TMCM we that is highly conserved the Corynebacterineae because activity is for of at are known to in C. glutamicum Sousa-D'Auria C. R. Puech V. M. G. Houssin C. Daffe M. FEMS Microbiol. 2003; PubMed Scopus Google Scholar) and three in M. tuberculosis V. Guilhot C. M. Daffe M. Mol. Microbiol. 2002; PubMed Scopus Google Scholar), with a of functional between the data that the two of transfer in their on the mycolate is that the of the of the for mycolates to AG with the of these the that form TDCM from The of De Sousa-D'Auria Sousa-D'Auria C. R. Puech V. M. G. Houssin C. Daffe M. FEMS Microbiol. 2003; PubMed Scopus Google Scholar) that the from C. glutamicum in their with and to transfer a from one TMCM to to form TDCM but and of to this with we that the of and are by the of the unreduced β-keto be to the of the gene in mycobacteria. have recently a mutant of the orthologue of Rv2509 in Mycobacterium and indicate that strain has a to the C. glutamicum and from the mutant have on of mycolic acids are and a has been involve of these mycolic acid of the mutant with Rv2509 and and intracellular to the importance of mycolates in The of an sequence a for CmrA, are in Corynebacterineae. of the in M. involved in transport of mycolates of the cell that the mycolic acids contained the mycolate the unreduced β-keto ester motif G.S. Lee R.E. Slayden R.A. P.J. K. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). but highly was identified in C. also a mycolic motif K. PubMed Scopus Google Scholar). this is in with an by (9Portevin D. de Sousa-D'Auria C. Montrozier H. Houssin C. Stella A. Laneelle M.A. Bardou F. Guilhot C. Daffe M. J. Biol. Chem. 2005; 280: 8862-8874Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar, 11Portevin D. De Sousa-D'Auria C. Houssin C. Grimaldi C. Chami M. Daffe M. Guilhot C. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 314-319Crossref PubMed Scopus (272) Google Scholar) and (13Takayama K. Wang C. Besra G.S. Clin. Microbiol. Rev. 2005; 18: 81-101Crossref PubMed Scopus (479) Google Scholar), proposed that reduction in the the mycolate is to by (4Tropis M. Meniche X. Wolf A. Gebhardt H. Strelkov S. Chami M. Schomburg D. Kramer R. Morbach S. Daffe M. J. Biol. Chem. 2005; 280: 26573-26585Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar) proposed an for the reduction attachment of a mycolate to which is by the data focus on the structural characterization of and with mycolic acid with the of The sequence between all that the enzyme in is highly that is for esterification of AG with mycolic acids in human pathogens M. tuberculosis and M. leprae. Despite being in M. tuberculosis, of with drugs be to the intracellular and of the this enzyme an target for future drug for for C. glutamicum ATCC 13032, and and for
25
Basic local alignment search tool
Stephen F. Altschul, Warren Gish, Webb Miller et al. · Journal of Molecular Biology · 1990 · 94.5K citations
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Stewart T. Cole, Roland Brosch, Julian Parkhill et al. · Nature · 1998 · 7.9K citations · Full text
Andreas Schäfer, Andreas Tauch, Wolfgang Jäger et al. · Gene · 1994 · 2.8K citations